EUVIMEDEUVIMED entdecken
Crossref

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Yixin Liu, Chunfei Zhang, Xiao Zhang, Chunping Wan, Zewei Mao iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yixin Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Benzofurans, Antineoplastic Agents, Chalcones. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Key Project of Applied Basic Research of Yunnan Province, Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery and development of efficient VEGFR‐2 inhibitors has become a research hotspot in cancer treatment. In this work, a series of new benzofuran‐based chalcone derivatives have been prepared, and in vitro anticancer activities have been evaluated. The results revealed that derivatives showed selective cytotoxic activity against HCC1806, Hela, and A549 cell lines, especially 5c exhibited excellent inhibitory effect on VEFGR‐2 (IC 50 = 1.07 nM). The molecular docking study indicated that 5c had an obvious binding site with the target VEGFR‐2 (PDB ID: 3V6B). Therefore, the benzofuran‐based chalcone derivatives could be considered as potent VEGFR‐2 inhibitors for further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2BenzofuransAntineoplastic AgentsChalconesProtein Kinase InhibitorsChalconeHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular Docking SimulationCell ProliferationCell Line, TumorMolecular StructureDose-Response Relationship, DrugBinding Sites

Stichwörter der Autor:innen

VEGFR‐2 inhibitorsanticancer activitybenzofuranchalconemolecular docking

Substanzen

Vascular Endothelial Growth Factor Receptor-2BenzofuransAntineoplastic AgentsChalconesbenzofuranProtein Kinase InhibitorsChalconeKDR protein, human

Autor:innen und Institutionen

  • School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China.
  • Chuxiong Autonomous Prefecture Hospital of Traditional Chinese Medicine, Chuxiong, China.

ORCID-Profile: Zewei Mao

Förderung

  • Key Project of Applied Basic Research of Yunnan Province
  • Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Chinese Medicine

Zitieren

APA

Liu, Y., Zhang, C., Zhang, X., Wan, C., & Mao, Z. (2025). Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401991

Vancouver

Liu Y, Zhang C, Zhang X, Wan C, Mao Z. Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401991

BibTeX
@article{Liu2025,
  author = {Liu, Yixin and Zhang, Chunfei and Zhang, Xiao and Wan, Chunping and Mao, Zewei},
  title = {Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401991}
}
Kostenlos starten →